A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Regulatory actions for Jan. 5, 2026
Regulatory actions for Jan. 5, 2026
Biggest gainers and losers for Dec. 29, 2025-Jan. 2, 2026
Biggest gainers and losers for Dec. 29, 2025-Jan. 2, 2026
Psithera spun out of Roivant with $47.5M and immune, inflammatory focus
Psithera spun out of Roivant with $47.5M and immune, inflammatory focus
New Nav1.8 blockers disclosed in Jumpcan Pharmaceutical patent
New Nav1.8 blockers disclosed in Jumpcan Pharmaceutical patent
Chinese scientists discover new NMDA and serotonin receptor antagonists
Chinese scientists discover new NMDA and serotonin receptor antagonists
Holiday notice
Holiday notice
Other news to note for Jan. 2, 2026
Other news to note for Jan. 2, 2026
Regulatory actions for Jan. 2, 2026
Regulatory actions for Jan. 2, 2026
Money raised by biopharma
Money raised by biopharma
Biopharma money raised: Jan. 1-Dec. 31, 2025
Biopharma money raised: Jan. 1-Dec. 31, 2025
BioWorld and Nasdaq stock indices
BioWorld and Nasdaq stock indices
Holiday notice
Holiday notice
Vanda stock jumps with FDA approval of motion sickness drug
Vanda stock jumps with FDA approval of motion sickness drug
Corcept looks to ovarian cancer as relacorilant gets CRL in Cushing
Corcept looks to ovarian cancer as relacorilant gets CRL in Cushing
Blossomhill advancing EGFR, CLK inhibitors with series B extension
Blossomhill advancing EGFR, CLK inhibitors with series B extension
Axsome’s Auvelity for Alzheimer’s agitation gets priority review
Axsome’s Auvelity for Alzheimer’s agitation gets priority review
CMR, Medtronic secure FDA nod for robotic surgical systems
CMR, Medtronic secure FDA nod for robotic surgical systems
Med-tech IPOs shoot for the stars in 2025
Med-tech IPOs shoot for the stars in 2025
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page